IMGO

imGO

#Financial #More

IMGO

Status:
Active


Investments List

Date Company Article Money raised
2002-04-19 IP Infusion imGO investment in Series C - IP Infusion 14.7 M USD
2001-07-12 Ness Display Corp imGO investment in Series B - Ness Display Corp 15 M USD

More informations about "imGO" on Search Engine

Who We Are - IMAGO Global Grassroots

We are a diverse a multidisciplinary team helping organizations reach their maximum potential. Our Team. Board. Founding board. Advisors. Summer Fellows. Research โ€ฆSee details»

Home - IMAGO Global Grassroots

A world in which the innovations and solutions developed at the grassrootscan reach global scale. Our Vision. Changing development thinking and practicesaround poverty alleviation. Our Impact in โ€ฆSee details»

What We Do - IMAGO Global Grassroots

1. Diagnosis, Strategy & Action. IMAGO has developed a unique and robust 3-stage process to support organizations achieve transformative impact. Through interviews, workshops, field visits and virtual check-ins, IMAGO โ€ฆSee details»

What are the Strengths, Weaknesses, Opportunities and Threats โ€ฆ

Imago BioSciences, Inc. (IMGO) faces several opportunities that can contribute to its growth and success in the biotechnology industry. Market Expansion: IMGO has the opportunity โ€ฆSee details»

Imago BioSciences - Funding, Financials, Valuation & Investors

Funding. Imago BioSciences has raised a total of. $146.5M. in funding over 3 rounds. Their latest funding was raised on Nov 19, 2020 from a Series C round. Imago BioSciences is โ€ฆSee details»

Imago BioSciences - Crunchbase Company Profile & Funding

Details. Industries. Biotechnology. Life Science. Therapeutics. Headquarters Regions San Francisco Bay Area, Silicon Valley, West Coast. Founded Date 2012. Founders Hugh โ€ฆSee details»

Merck to Acquire Imago BioSciences, Inc. - Merck.com

Save. November 21, 2022 6:45 am ET. Acquisition expands Merckโ€™s growing hematology portfolio. RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD โ€ฆSee details»

Merck to buy Imago for $1.35 bln to broaden portfolio โ€ฆ

Nov 21 (Reuters) - Merck & Co Inc (MRK.N) said on Monday it will acquire cancer drug developer Imago BioSciences Inc (IMGO.O) for a total equity value of $1.35 billion to expand its portfolio of...See details»

imGO - Crunchbase Investor Profile & Investments

PRNewswire โ€” SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Imago BioSciences, Inc. - IMGO News โ€ข Jul 26, 2021 BioSpace โ€” Imago โ€ฆSee details»

Cancer-Focused Imago BioSciences Shares Soar After Merck Deal

Mon, Nov 21, 2022, 8:55 AM 1 min read. In this article: MRK. Merck & Co Inc (NYSE: MRK) has agreed to acquire Imago BioSciences Inc (NASDAQ: IMGO) for $36.00 per share in โ€ฆSee details»

Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.

January 11, 2023 6:45 am ET. RAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the โ€ฆSee details»

Imago BioSciences Reports Fourth Quarter and Full Year 2021 โ€ฆ

Mar 24, 2022 SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (โ€œImagoโ€) (Nasdaq: IMGO), a clinical stage biopharmaceutical โ€ฆSee details»

Administer the Imago Portal โ€“ Imago

Once you have filled out the Support Request Form, and clicked the submit button, your support request will be automatically logged into our internal database and you will be โ€ฆSee details»

Imago BioSciences: The Bone Marrow Cancer Researcher โ€ฆ

Nov 30, 2022 Imago BioSciences, Inc. ( IMGO ), a U.S. biotech developer of innovative treatments for bone marrow cancer patients, will become part of the Merck & Co., Inc. ( โ€ฆSee details»

Images of Organization | SAGE Publications Inc

Images of Organization challenges and reshapes how we think about organization and management in the most fundamental way. The new Updated Edition makes this โ€ฆSee details»

Merck to Acquire Imago BioSciences, Inc. | Business Wire

Nov 21, 2022 RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago โ€ฆSee details»

About โ€“ IMAGO

IMAGO is the International Federation of Cinematographers. It is an active global network created to bring cinematographers together to discuss solutions to common challenges, โ€ฆSee details»

International Nongovernmental Organizations (INGOs)

Nov 29, 2020 INGOs can be divided into service organizations, such as CARE International, that seek to provide direct humanitarian relief or economic development โ€ฆSee details»

Imago BioSciences Reports First Quarter 2022 Financial

May 12, 2022 SOUTH SAN FRANCISCO, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (โ€œImagoโ€) (Nasdaq: IMGO), a clinical stage biopharmaceutical โ€ฆSee details»

Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck

Tue, Nov 22, 2022, 12:53 PM 3 min read. In this article: MRK. Shares of Imago BioSciences IMGO skyrocketed 104% on Nov 21 after the company announced that it has signed a โ€ฆSee details»